🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
VYG
$VYGR
🔒 US EquitiesVoyager Therapeutics Inc
AVG HISTORICAL GAP
+1.22%
MAX GAP RECORD
+10.81%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $VYGR
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$VYGR
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE) |
-1.92%
|
| May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE) |
-1.01%
|
| Mar 09, 2026 Earnings Release 2026-03-09 (AFTER CLOSE) |
+0.00%
|
| Nov 10, 2025 Earnings Release 2025-11-10 (BEFORE OPEN) |
+0.00%
|
| Aug 06, 2025 Earnings Release 2025-08-06 (AFTER CLOSE) |
+0.00%
|
| May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE) |
-0.31%
|
| Mar 11, 2025 Earnings Release 2025-03-11 (AFTER CLOSE) |
-4.28%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE) |
+2.78%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.2%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (2)
📖 Intelligence Summary
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗